Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.

Anand, A

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. [electronic resource] - Cancer May 1996 - 1959-60 p. digital

Publication Type: Comment; Letter

0008-543X

10.1002/(SICI)1097-0142(19960501)77:9<1959::AID-CNCR32>3.0.CO;2-X doi


Antibiotics, Antineoplastic--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Alkylating--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cisplatin--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Humans
Mesothelioma--drug therapy
Pleural Neoplasms--drug therapy
Prospective Studies
Remission Induction